Health Utility

Health state utility values for Non-small cell lung cancer (NSCLC)

SN Health state Country Value (mean) Measure
1 Stable disease with no toxicity UK 0.653 SG
2 Responding disease UK 0.700 SG
3 Progressive disease UK 0.473 SG
4 End of life UK 0.330 SG
5 Progression free disease (1st line) UK 0.690 (sd=0.258) EQ-5D
6 Progression free disease (2nd line) UK 0.697 (sd=0.221) EQ-5D
7 Progression free disease (3rd line) UK 0.609 (sd=0.324) EQ-5D
8 Progressive disease (1st line) UK 0.608 (sd=0.237) EQ-5D
9 Progressive disease (2nd line) UK 0.550 (sd=0.353) EQ-5D
10 Progressive disease (3rd line) UK 0.418 (sd=0.399) EQ-5D
11 Stable disease UK 0.682 EQ-5D
12 Patients without Severe AE Netherlands 0.80 (sd=0.20) EQ-5D
13 Patients with Severe AE Netherlands 0.45 (sd=0.33) EQ-5D
14 Taking surgery alone Netherlands 0.77 (sd=0.25) EQ-5D
15 Taking chemotherapy alone Netherlands 1.00 EQ-5D
16 Taking radiotherapy alone Netherlands 0.62 (sd=0.24) EQ-5D
17 Taking surgery + radiotherapy Netherlands 0.86 (sd=0.12) EQ-5D
18 Taking surgery + radiotherapy + chemotherapy Netherlands 0.72 (sd=0.22) EQ-5D
19 Near death UK 0.15 EQ-5D
20 Treatment response UK 0.49 EQ-5D
21 Stable disease receiving IV therapy UK 0.43 EQ-5D
22 Stable disease receiving oral therapy UK 0.45 EQ-5D
23 Progressive disease UK 0.22 EQ-5D
24 Stable disease UK 0.626 EQ-5D
25 Progression free patients (1st line) UK 0.71 (sd=0.24) EQ-5D
26 Progression free patients (2nd line) UK 0.74 (sd=0.18) EQ-5D
27 Progression free patients (3rd/4th line) UK 0.62 (sd=0.29) EQ-5D

Please Login to Comment on This Article..